Skip to main content
SpringerLink
Log in

Antikoagulative Strategie bei stabiler kardiovaskulärer Erkrankung

COMPASS

Cardiovascular outcomes for people using anticoagulation strategies

COMPASS

  • Klinische Studien
  • Published:
Der Internist Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Caldeira D, Barra M, Pinto FJ, Ferreira JJ, Costa J (2015) Intracranial hemorrhage risk with the new oral anticoagulants: a systematic review and meta-analysis. J Neurol 262:516–522

    Article  PubMed  CAS  Google Scholar 

  2. Collaborative overview of randomised trials of antiplatelet therapy – i: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet trialists’ collaboration. BMJ (Clinical research ed.). 1994;308:81–106. http://www.bmj.com/content/308/6921/81.long

  3. Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O’Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Stork S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S (2017) Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377:1319–1330

    Article  PubMed  CAS  Google Scholar 

  4. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9–19

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kardiologie und Angiologie I, Universitäts-Herzzentrum Freiburg – Bad Krozingen, Hugstetter Str. 55, 79106, Freiburg, Deutschland

    M. Moser

  2. Lippetal, Deutschland

    S. Nitschmann

Authors
  1. M. Moser
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Nitschmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Moser.

Ethics declarations

Interessenkonflikt

M. Moser: Vortragshonorare: AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Lilly, Pfizer. Klinische Studien: Bayer, Bristol-Myers Squibb, Pfizer. S. Nitschmann gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

M. Hallek, Köln

W. Lehmacher, Köln

N. Marx, Aachen

U. Müller-Ladner, Bad Nauheim

H. Wedemeyer, Hannover

M. Wehling, Mannheim

T.R. Weihrauch, Düsseldorf

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Moser, M., Nitschmann, S. Antikoagulative Strategie bei stabiler kardiovaskulärer Erkrankung. Internist 59, 636–638 (2018). https://doi.org/10.1007/s00108-018-0407-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-018-0407-4

Search

Navigation